| Ytd | -24.37% | |
| 1y | -21.95% |
| Open | 506.48 | Prev Close | 506.48 | Low | 505.21 | High | 516.43 | Mkt Cap | 40.31B |
| Vol | 1.12M | Avg Vol | 602.88K | EPS | 14.23 | P/E | 35.96 | Forward P/E | 30.57 |
| Beta | 1.54 | Short Ratio | 3.41 | Inst. Own | 96.74% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-02 | 50-d Avg | 551.88 | 200-d Avg | 598.53 | 1yr Est | 698.92 |
IDEXX Laboratories NASDAQ: IDXX executives highlighted the company's diagnostic innovation pipeline,
IDEXX Laboratories NASDAQ: IDXX executives reiterated the company's long-term growth framework at th
IDXX shares rise 0.6% after the company acquires CoVet, expanding its AI-native software capabilitie
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announc
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX expands Faecal Dx™ antigen testing platform in the United K
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX announces acquisition of CoVetAI to advance veterinary work
IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference
InMode (NASDAQ: INMD - Get Free Report) and IDEXX Laboratories (NASDAQ: IDXX - Get Free Report) are
The transaction involved 2,203 shares at $532.08 per share for a total value of ~$1.2 million. The d
Baird Financial Group Inc. decreased its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 7.9%
Arizona State Retirement System raised its position in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 4.
California State Teachers Retirement System raised its holdings in shares of IDEXX Laboratories, Inc
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
Baron Focused Growth Fund rebounded in Q2 from a disappointing start to the year, with the Fund gain
[url="]IDEXX Laboratories, Inc.[/url] (Nasdaq: IDXX), a global leader in pet healthcare innovation,
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (Nasdaq: IDXX), a global leader in pet h
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
American Capital Management Inc. bought a new position in shares of IDEXX Laboratories, Inc. (NASDAQ
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
IDXX's CAG diagnostics and cloud software growth support recurring revenues, while FX exposure and d
IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international e
IDEXX pairs resilient diagnostics growth, margin gains and expanding innovation with a premium valua
Barclays analyst Glen Santangelo maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises t
Citigroup analyst Daniel Grosslight maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and
IDEXX Laboratories (IDXX) stock rose after reporting Q2 earnings of $4.27/share and $1.22B in revenu
IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter financial results on Tuesday. The transcrip
IDEXX Laboratories (NASDAQ:IDXX) raises FY2026 GAAP EPS guidance from $14.45-$14.90 to $14.69-$14.94
IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $4.27 per share which beat the analy
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t
Idexx Laboratories shares edge higher as revenue tops estimates but earnings per share misses; guida
IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $3.47 per share which beat the analy
IDEXX Laboratories (NASDAQ:IDXX) raises FY2026 GAAP EPS guidance from $14.29-$14.80 to $14.45-$14.90
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t
Citigroup analyst Daniel Grosslight initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a
Stifel analyst Jonathan Block maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers th
Piper Sandler analyst David Westenberg maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral
Barclays analyst Glen Santangelo maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and
UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and lowers t
BTIG analyst Mark Massaro maintains IDEXX Laboratories (NASDAQ:IDXX) with a Buy and lowers the pr
Dow Jones gains 500 points. Markets digest Trump's Fed chair nomination. CNN Money Fear & Gr
Wall Street rebounded at the start of the new month after Friday's broad sell-off, but pressure